NCT06868082View on ClinicalTrials.gov

A Study to Investigate Safety, Tolerability, and Pharmacokinetics of Solrikitug in Healthy Japanese and Non-Japanese Participants

PHASE1RecruitingINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

June 20, 2025

Primary Completion Date

August 30, 2025

Study Completion Date

December 31, 2025

Conditions

Healthy

Interventions

BIOLOGICAL

Solrikitug

Solrikitug Formulation 1

BIOLOGICAL

Solrikitug

Solrikitug Formulation 2

Trial Locations (1)

Unknown

RECRUITING

Research Site, Brisbane

All Listed Sponsors

lead

Uniquity One (UNI)

INDUSTRY